CRSP - Crispr Therapeutics AG - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - CRSP (1674416)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
24 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P9+5+11+20+13
S10-0+0+0+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-06-22
CRSPNovak RodgerCEOS - Sale+OE$15.37-10,8251,215,005-1%-$166,388
DM
2017-06-19
CRSPNovak RodgerCEOS - Sale+OE$15.01-30,2221,215,005-2%-$453,511
DM
2017-06-08
CRSPNovak RodgerCEOS - Sale+OE$15.02-5,3031,215,0050%-$79,628
D
2017-05-30
CRSPNovak RodgerCEOS - Sale+OE$15.02-3,6501,215,0050%-$54,829
DM
2017-05-16
CRSPNovak RodgerCEOS - Sale+OE$16.26-50,0001,215,005-4%-$812,859
D
2017-05-05
CRSPNovak RodgerCEOS - Sale+OE$16.92-6161,215,0050%-$10,4260
DM
2017-05-02
CRSPNovak RodgerCEOS - Sale+OE$16.30-49,3841,215,005-4%-$805,183+2+2
2017-05-01
CRSPDylan-Hyde TylerGCS - Sale$16.61-1,852168,204-1%-$30,753+3+4
DM
2017-04-26
CRSPKulkarni SamarthChief Business OfficerS - Sale+OE$16.76-5,481134,047-4%-$91,8390-2
M
2017-04-26
CRSPDylan-Hyde TylerGCS - Sale$16.78-21,639170,056-11%-$363,0770-2
M
2017-04-21
CRSPDylan-Hyde TylerGCS - Sale$16.78-11,332183,695-6%-$190,109-1+1
DM
2017-04-21
CRSPKulkarni SamarthChief Business OfficerS - Sale+OE$16.78-11,615134,047-8%-$194,942-1+1
DM
2017-04-19
CRSPNovak RodgerCEOS - Sale+OE$17.88-50,0001,215,005-4%-$893,918-20
DM
2017-04-19
CRSPKulkarni SamarthChief Business OfficerS - Sale+OE$17.73-10,058134,047-7%-$178,376-20
M
2017-04-19
CRSPDylan-Hyde TylerGCS - Sale$17.71-10,177195,027-5%-$180,190-20
D
2016-10-24
CRSPEmster Kurt VonDirP - Purchase$14.00+56,0002,601,814+2%+$784,000+9+24+42
D
2016-10-24
CRSPLundberg Sven AnteChief Scientific OfficerP - Purchase$14.00+4001,010,8340%+$5,600+2+25+43
AD
2016-10-24
CRSPVersant Venture Capital Iv, L.P.10%P - Purchase$14.00+161,00079,478-197%+$2,254,000+1-3-10
D
2016-10-24
CRSPWoiwode ThomasDirP - Purchase$14.00+161,000763,492+27%+$2,254,000+1-3-10
D
2016-10-24
CRSPBolzon Bradley J PhdDirP - Purchase$14.00+161,000763,492+27%+$2,254,000+1-3-10
AD
2016-10-24
CRSPCelgene Corp /de/10%P - Purchase$14.00+800,1504,834,980+20%+$11,202,100+6-3+31+8
D
2016-10-24
CRSPGeorge SimeonDirP - Purchase$14.00+66,5003,220,627+2%+$931,000+7+22+31+15
D
2016-10-24
CRSPGlaxosmithkline Plc10%P - Purchase$14.00+66,5003,220,627+2%+$931,000+7+22+31+15
D
2016-10-24
CRSPCelgene Corp /de/10%P - Purchase$14.00+800,1504,834,980+20%+$11,202,100+7+22+31+15

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top